MEDIJEL Oral gel Ref.[28073] Active ingredients: Aminoacridine Lidocaine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: DENDRON BRANDS LIMITED, 94, Rickmansworth Road, Watford, Hertfordshire, WDI8 7JJ, United Kingdom

Product name and form

MEDIJEL GEL.

Pharmaceutical Form

Oral gel.

Qualitative and quantitative composition

Lidocaine hydrochloride BP 0.66% w/w.

Aminoacridine hydrochloride BP 1968 0.05% w/w.

Active Ingredient Description
Aminoacridine
Lidocaine

Lidocaine, like other local anaesthetics, causes a reversible blockade of impulse propagation along nerve fibres by preventing the inward movement of sodium ions through the nerve membrane. Local anaesthetics of the amide-type are thought to act within the sodium channels of the nerve membrane.
List of Excipients

Glycerol
Hydroxypolyethoxydodecane HSE
Alcohol 96% v/v
Carbomer
Sucrose
Saccharin sodium
Peppermint oil
Ethyl vanillin
Di-isopropanolamine 90% aqueous
Purified water

Pack sizes and marketing

Aluminium tube with membrane seal and spiked polyethylene cap.

Pack size: 15g.

Marketing authorization holder

DENDRON BRANDS LIMITED, 94, Rickmansworth Road, Watford, Hertfordshire, WDI8 7JJ, United Kingdom

Marketing authorization dates and numbers

PL 52731/0007

19/05/2003

Drugs

Drug Countries
MEDIJEL Cyprus, Hong Kong, Ireland, New Zealand, Singapore, United Kingdom
 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈